Evaluation and molecular analysis of circulating tumor cells using the On-chip Sort for patients with non-small cell lung cancer

Evaluation and molecular analysis of circulating tumor cells using the On-chip Sort for patients with non-small cell lung cancer - Evaluation and molecular analysis of CTCs using the On-chip Sort for patients with NSCLC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012488

Enrollment

Registered

2013-12-04

Start date

2013-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients with pathologically proven non-small cell lung cancer 2) age >= 20 years 3) signed informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Evaluation of CTCs using the On-chip Sort	—

Secondary

Measure	Time frame
Association between CTCs count and prognosis. Evaluation of the antigen in CTCs Molecular analysis of isolated CTC	—

Countries

Japan

Contacts

Public ContactHirotsugu Kenmotsu

Shizuoka Cancer Center Division of Thoracic Oncology

h.kenmotsu@scchr.jp+81-55-989-5222

Outcome results